Correspondence 0001493152-25-008285 from Telomir Pharmaceuticals, Inc. (TELO) (CIK 0001971532) (TELO)
Telomir Pharmaceuticals, Inc. (TELO) (CIK 0001971532)
Date: Feb. 26, 2025 · CIK: 0001971532 · Accession: 0001493152-25-008285
AI Filing Summary & Sentiment
File numbers found in text: 333-284990
Letter
Telomir Pharmaceuticals, Inc.
SE 2nd St, Suite 2000, #1009
Miami, Florida
February 26, 2025
VIA EDGAR
U.S. Securities & Exchange Commission
Division of Corporation Finance
Office of Life Sciences
F Street, N.E.
Washington, D.C. 20549
Re: Telomir Pharmaceuticals, Inc.
Registration Statement on Form S-3
File No. 333-284990
Ladies and Gentlemen:
In accordance with Rule 461 of the Securities Act of 1933, as amended, Telomir Pharmaceuticals, Inc. hereby respectfully requests that the effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 9:00 a.m. Eastern Time on Friday, February 28, 2025, or as soon thereafter as possible.
* * * *
Very
Truly Yours,
Telomir Pharmaceuticals, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Telomir
Pharmaceuticals, Inc.
100
SE 2nd St, Suite 2000, #1009
Miami,
Florida
February
26, 2025
VIA
EDGAR
U.S.
Securities & Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Telomir Pharmaceuticals,
Inc.
Registration Statement
on Form S-3
File No. 333-284990
Ladies
and Gentlemen:
In
accordance with Rule 461 of the Securities Act of 1933, as amended, Telomir Pharmaceuticals, Inc. hereby respectfully requests that the
effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 9:00 a.m. Eastern
Time on Friday, February 28, 2025, or as soon thereafter as possible.
*
* * *
Very
Truly Yours,
Telomir Pharmaceuticals, Inc.
/s/ Erez
Aminov
Erez Aminov
Chief Executive Officer